The FDA Revokes Its Emergency Use Authorization for Hydroxychloroquine
Jun 22, 2020
08:50
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
So far, no studies have shown that the anti-malarial drug can fight Covid-19, and agency officials say its potential benefits do not outweigh its risks.
